Wendy Seiferheld
About
Wendy Seiferheld is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology.
According to data from OpenAlex, Wendy Seiferheld has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Genetics and 8 papers in Oncology. Recurrent topics in Wendy Seiferheld's work include Glioma Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Wendy Seiferheld is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Wendy Seiferheld collaborates with scholars based in United States, Canada and France. Wendy Seiferheld's co-authors include Christopher J. Schultz, Lisa M. DeAngelis, Barbara Fisher, S. Clifford Schold, Walter J. Curran, Minesh P. Mehta, William T. Sause, David Brachman, Jan C. Buckner and Luís Souhami and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Neuro-Oncology.
In The Last Decade
Wendy Seiferheld
32 papers receiving 1.7k citations
Hit Papers
Peers
Wendy Seiferheld
Guido Sotti Italy
B. Fisher Canada
Igor T. Gavrilovic United States
Maryline Barrié France
Merideth M Wendland United States
Laëtitia Padovani France
Joseph M. Jenrette United States
M.G. Glaser United Kingdom
Minhee Won United States
Sten Myrehaug Canada
Citations per year, relative to Wendy Seiferheld Wendy Seiferheld (= 1×)
peers
Guido Sotti
Countries citing papers authored by Wendy Seiferheld
Since
Specialization
Citations
This map shows the geographic impact of Wendy Seiferheld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Seiferheld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Seiferheld more than expected).
Fields of papers citing papers by Wendy Seiferheld
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Wendy Seiferheld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Seiferheld. The network helps show where Wendy Seiferheld may publish in the future.
Co-authorship network of co-authors of Wendy Seiferheld
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Seiferheld. A scholar is included among the top collaborators of Wendy Seiferheld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Seiferheld. Wendy Seiferheld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lukka, Himu, Stephanie L. Pugh, William U. Shipley, et al.. (2025). Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy. International Journal of Radiation Oncology*Biology*Physics. 123(4). 990–999.
2.
Kwak, Lucia, Praful Ravi, John G. Armstrong, et al.. (2024). Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of Clinical Oncology. 42(18). 2132–2138.
3.
Ravi, Praful, Lucia Kwak, John Armstrong, et al.. (2023). Prognostic impact of PSA nadir (n) ≥0.1 ng/mL within 6 months (m) after completion of radiotherapy (RT) for localized prostate cancer (PCa): An individual patient-data (IPD) analysis of randomized trials from the ICECAP collaborative.. Journal of Clinical Oncology. 41(16_suppl). 5002–5002.
4.
Kishan, Amar U., Xiaoyan Wang, Wendy Seiferheld, et al.. (2018). Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes. JAMA Oncology. 5(1). 91–91.
5.
Lustig, Robert A., Wendy Seiferheld, Brian Berkey, et al.. (2007). Imaging Response in Malignant Glioma, RTOG 90-06. American Journal of Clinical Oncology. 30(1). 32–37.
6.
Robins, H. Ian, Minhee Won, Wendy Seiferheld, et al.. (2006). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211. Neuro-Oncology. 8(1). 47–52.
7.
Chakravarti, Arnab, Wendy Seiferheld, Xiaoyu Tu, et al.. (2005). Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: Report from the Radiation Therapy Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 62(2). 318–327.
8.
Fisher, Barbara, Wendy Seiferheld, Christopher J. Schultz, et al.. (2005). Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma. Journal of Neuro-Oncology. 74(2). 201–205.
9.
Souhami, Luís, Wendy Seiferheld, David Brachman, et al.. (2004). Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. International Journal of Radiation Oncology*Biology*Physics. 60(3). 853–860.
10.
Chang, Susan M., Wendy Seiferheld, Walter J. Curran, et al.. (2004). Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. International Journal of Radiation Oncology*Biology*Physics. 59(4). 1122–1126.
11.
Seiferheld, Wendy, Emily Shaw, Roger L. Jenkins, et al.. (2004). An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94–02. Journal of Clinical Oncology. 22(14_suppl). 1500–1500.
12.
Brat, Daniel J., Wendy Seiferheld, Arie Perry, et al.. (2004). Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-gradeastrocytomas using fluorescence in situ hybridization on tissue microarraysfrom Radiation Therapy Oncology Group trials. Neuro-Oncology. 6(2). 96–103.
13.
Prados, Michael D., Wendy Seiferheld, Howard M. Sandler, et al.. (2004). Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. International Journal of Radiation Oncology*Biology*Physics. 58(4). 1147–1152.
14.
Werner‐Wasik, Maria, Wendy Seiferheld, Jeff M. Michalski, et al.. (2004). Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98–03 protocol. International Journal of Radiation Oncology*Biology*Physics. 60(1). S163–S164.
15.
Cairncross, Gregory, Wendy Seiferheld, Rachel Jenkins, et al.. (2004). An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94–02. Journal of Clinical Oncology. 22(14_suppl). 1500–1500.
16.
Chakravarti, Arnab, Wendy Seiferheld, H. Ian Robins, et al.. (2004). An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib+ radiation for newly-diagnosed glioblastoma (GBM) patients. Journal of Clinical Oncology. 22(14_suppl). 1571–1571.
17.
Shaw, Edward G., Wendy Seiferheld, Charles Scott, et al.. (2003). Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. International Journal of Radiation Oncology*Biology*Physics. 57(2). S135–S136.
18.
Komaki, Ritsuko, Wendy Seiferheld, David S. Ettinger, et al.. (2002). Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. International Journal of Radiation Oncology*Biology*Physics. 53(3). 548–557.
19.
Cleeland, Charles S., Nora A. Janjan, Charles Scott, Wendy Seiferheld, & Walter J. Curran. (2000). Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians. International Journal of Radiation Oncology*Biology*Physics. 47(1). 203–208.
20.
Machtay, Mitchell, Wendy Seiferheld, Ritsuko Komaki, et al.. (1999). Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: analysis of the radiation therapy oncology group experience. International Journal of Radiation Oncology*Biology*Physics. 44(4). 847–853.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Guido Sotti Breakdown of academic impact, for papers by B. Fisher Breakdown of academic impact, for papers by Igor T. Gavrilovic Breakdown of academic impact, for papers by Maryline Barrié Breakdown of academic impact, for papers by Merideth M Wendland Breakdown of academic impact, for papers by Laëtitia Padovani Breakdown of academic impact, for papers by Joseph M. Jenrette Breakdown of academic impact, for papers by M.G. Glaser Breakdown of academic impact, for papers by Minhee Won Breakdown of academic impact, for papers by Sten Myrehaug